Breast Cancer and the Problem of Ethnicity

Breast Cancer and the Problem of Ethnicity

Breast cancer is one of the most widespread cancers influencing American women, and is second simply to lung cancer as a principal cause of cancer death in women. The number of its cases has been on the increase as long as the past 20 years, while the death rate from breast cancer has declined slightly in the past five years. The rise in cases is connected, partly, to a greater stress on screening with routine breast exams and mammography.

All women ought to be conscious of their risk for breast cancer; it could have an effect on women of every age, race and ethnic group. However, the rates of rising and dying from the disease are various amongst a range of racial and ethnic groups.

As maintained by the National Cancer Institute, white, non-Hispanic women have the highest overall incidence rate for breast cancer amongst U.S. racial/ethnic groups, at the same time as Korean American women have the lowest rate. Amongst women ages 40-50, African American women have a higher frequency of the disease than white women. African American women have the highest death (death) rate too from breast cancer; Chinese American women have the lowest mortality rate.

A number of factors have been established to impact the breast cancer numbers and mortality rates amongst racial and ethnic groups. Distinctions in particular lifestyle behaviors — like diet, exercise, and acceptability of smoking and alcohol utilization could affect the risk of a lot of diseases, including heart disease and breast cancer.

The higher mortality rate from breast cancer amongst African American women has been connected to the stage, or extent, of the cancer at diagnosis. Studies demonstrate that African American women have a tendency to look for treatment when their cancer is in a more advanced, less treatable stage.

Emerging evidence implies that certain drugs might help people from one ethnic group more than others, due to dissimilarities in their genetic structure. However, most main trials looking at treatments for breast cancer have been completed in mainly white populations in Europe, North America and also Australasia.

Other populations may not react to a drug in the similar way as the white populations in these trials, claim the researchers writing nowadays. They put forward that clinical trials must record participants’ ethnicity and investigate whether there are distinctions in how patients from certain ethnic groups react to a certain therapy..

Breast Cancer and the Problem of Ethnicity

Leave a Reply

Your email address will not be published. Required fields are marked *